One assay, a range of applications.
A single assay tailored to fit your needs—today and in the future.
Comprehensive analysis of current, novel, and emerging biomarkers¹
Expanded genotyping panel to inform treatment selection of next-generation cancer therapeutics¹
Methylation profiling for increased accuracy and precision of ctDNA detection¹
Improved patient stratification from promoter methylation status of IO, HLA, IFN, HRD, and tumor suppressor genes¹
ctDNA, circulating tumor DNA; HLA, human leukocyte antigen; HRD, homologous recombination deficiency; IO, immuno-oncology.
Home GuardantINFINITY™ FDA Approved Guardant360® CDx Guardant Reveal™ Guardant Infinity Platform™